Takeda Agrees to Pay $13.6M to Resolve False Claims Allegations Relating to Improper Payments to Physicians
Takeda Pharmaceuticals, U.S.A. Inc. has agreed to pay $13,670,921 to resolve allegations that it knowingly caused the submission of false claims to Medicare and other federal health care programs by paying kickbacks to healthcare providers to induce prescriptions of Trintellix, an antidepressant medication that Takeda marketed and sold to treat major depressive disorder.
More About This Action
Action Details
- Date:May 14, 2026
- Agency:U.S. Department of Justice
-
Enforcement Types:
- Criminal and Civil Actions